We've found
184,457
clinical trials
BIPOLAR DISORDER Clinical Trial
Metformin for Overweight & OBese ChILdren and Adolescents With BDS Treated With SGAs
Status: Enrolling,
Phase
IV
Updated: 6/1/2016
Click here to add this to my saved trials
Mesothelioma Clinical Trial
MEDI4736 Or MEDI4736 + Tremelimumab In Surgically Resectable Malignant Pleural Mesothelioma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Other Clinical Trial
Registry for Cardiogenic Shock: Utility and Efficacy of Device Therapy
Status: Enrolling
Updated: 6/2/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Other Clinical Trial
Registry for Cardiogenic Shock: Utility and Efficacy of Device Therapy
Status: Enrolling
Updated: 6/2/2016
Click here to add this to my saved trials
Hypertension Clinical Trial
Pharmacodynamic Equivalence of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular (CV) Polypill Acetylsalicylic Acid-Atorvastatin-Ramipril (AAR) as Compared to Monotherapy
Status: Enrolling,
Phase
II
Updated: 4/3/2017
Click here to add this to my saved trials
Hypertension Clinical Trial
Pharmacodynamic Equivalence of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular (CV) Polypill Acetylsalicylic Acid-Atorvastatin-Ramipril (AAR) as Compared to Monotherapy
Status: Enrolling,
Phase
II
Updated: 4/3/2017
Click here to add this to my saved trials
Hypertension Clinical Trial
Pharmacodynamic Equivalence of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular (CV) Polypill Acetylsalicylic Acid-Atorvastatin-Ramipril (AAR) as Compared to Monotherapy
Status: Enrolling,
Phase
II
Updated: 4/3/2017
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
Phase 4 Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Durvalumab in Pediatric and Adolescent Patients
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study to Assess the Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
SPECT/CT Imaging of Skeletal Muscle Perfusion
Status: Enrolling
Updated: 10/26/2017
Click here to add this to my saved trials
HIV INfections Clinical Trial
Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Patent Ductus Arteriosus Clinical Trial
PDA Post NICU Discharge
Status: Enrolling,
Phase
Updated: 4/27/2018
Click here to add this to my saved trials
Patent Ductus Arteriosus Clinical Trial
PDA Post NICU Discharge
Status: Enrolling,
Phase
Updated: 4/27/2018
Click here to add this to my saved trials
Patent Ductus Arteriosus Clinical Trial
PDA Post NICU Discharge
Status: Enrolling,
Phase
Updated: 4/27/2018
Click here to add this to my saved trials
Oncology Clinical Trial
Frameless Fractionated Stereotactic Radiation in Treating Patients With Brain Metastases
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
The Breast Program - Translational Cancer Resource
Status: Enrolling
Updated: 6/13/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Phase 1/2 Study of USL311 Alone and in Combination With Lomustine in Subjects With Advanced Solid Tumors and Relapsed/Recurrent Glioblastoma Multiforme (GBM)
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Liver Failure Clinical Trial
13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Liver Failure Clinical Trial
13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Liver Failure Clinical Trial
13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Pilot - Peri-operative Beta Blockade
Status: Enrolling,
Phase
IV
Updated: 6/16/2016
Click here to add this to my saved trials
Atherosclerotic Cardiovascular Disease Clinical Trial
Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Atherosclerotic Cardiovascular Disease Clinical Trial
Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Atherosclerotic Cardiovascular Disease Clinical Trial
Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Atherosclerotic Cardiovascular Disease Clinical Trial
Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Atherosclerotic Cardiovascular Disease Clinical Trial
Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Atherosclerotic Cardiovascular Disease Clinical Trial
Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Atherosclerotic Cardiovascular Disease Clinical Trial
Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Atherosclerotic Cardiovascular Disease Clinical Trial
Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Psychiatry / Psychology Clinical Trial
Blue Blockers and Insomnia
Status: Enrolling
Updated: 6/20/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab and BCG Solution in Treating Patients With Recurrent Non-Muscle-Invasive Bladder Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Ovarian Neoplasms Clinical Trial
Phase Ib Study of Anetumab Ravtansine in Combination With Pegylated Liposomal Doxorubicin in Patients With Recurrent Mesothelin-expressing Platinum-resistant Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Neoplasm Clinical Trial
18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Glaucoma Clinical Trial
The AGS Second Aqueous Shunt Implant vs. Transscleral Cyclophotocoagulation Treatment Study (ASSISTS)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Glaucoma Clinical Trial
The AGS Second Aqueous Shunt Implant vs. Transscleral Cyclophotocoagulation Treatment Study (ASSISTS)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Glaucoma Clinical Trial
The AGS Second Aqueous Shunt Implant vs. Transscleral Cyclophotocoagulation Treatment Study (ASSISTS)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Other Clinical Trial
Venous Leg Ulcer and Lymphedema Registry
Status: Enrolling,
Phase
Updated: 4/23/2018
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Glaucoma Clinical Trial
Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-1)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Glaucoma Clinical Trial
Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-1)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Glaucoma Clinical Trial
Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-3)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Glaucoma Clinical Trial
Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-3)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Glaucoma Clinical Trial
Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-3)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
We've found
184,457
clinical trials
BIPOLAR DISORDER Clinical Trial
Updated: 6/1/2016
Metformin for Overweight & OBese ChILdren and Adolescents With BDS Treated With SGAs
Status: Enrolling,
Phase
IV
Updated: 6/1/2016
Click here to add this to my saved trials
Mesothelioma Clinical Trial
Updated: 12/31/1969
MEDI4736 Or MEDI4736 + Tremelimumab In Surgically Resectable Malignant Pleural Mesothelioma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
Updated: 1/29/2018
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Other Clinical Trial
Updated: 6/2/2016
Registry for Cardiogenic Shock: Utility and Efficacy of Device Therapy
Status: Enrolling
Updated: 6/2/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Other Clinical Trial
Updated: 6/2/2016
Registry for Cardiogenic Shock: Utility and Efficacy of Device Therapy
Status: Enrolling
Updated: 6/2/2016
Click here to add this to my saved trials
Hypertension Clinical Trial
Updated: 4/3/2017
Pharmacodynamic Equivalence of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular (CV) Polypill Acetylsalicylic Acid-Atorvastatin-Ramipril (AAR) as Compared to Monotherapy
Status: Enrolling,
Phase
II
Updated: 4/3/2017
Click here to add this to my saved trials
Hypertension Clinical Trial
Updated: 4/3/2017
Pharmacodynamic Equivalence of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular (CV) Polypill Acetylsalicylic Acid-Atorvastatin-Ramipril (AAR) as Compared to Monotherapy
Status: Enrolling,
Phase
II
Updated: 4/3/2017
Click here to add this to my saved trials
Hypertension Clinical Trial
Updated: 4/3/2017
Pharmacodynamic Equivalence of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular (CV) Polypill Acetylsalicylic Acid-Atorvastatin-Ramipril (AAR) as Compared to Monotherapy
Status: Enrolling,
Phase
II
Updated: 4/3/2017
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
Phase 4 Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Durvalumab in Pediatric and Adolescent Patients
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Study to Assess the Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Updated: 10/26/2017
SPECT/CT Imaging of Skeletal Muscle Perfusion
Status: Enrolling
Updated: 10/26/2017
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Patent Ductus Arteriosus Clinical Trial
Updated: 4/27/2018
PDA Post NICU Discharge
Status: Enrolling,
Phase
Updated: 4/27/2018
Click here to add this to my saved trials
Patent Ductus Arteriosus Clinical Trial
Updated: 4/27/2018
PDA Post NICU Discharge
Status: Enrolling,
Phase
Updated: 4/27/2018
Click here to add this to my saved trials
Patent Ductus Arteriosus Clinical Trial
Updated: 4/27/2018
PDA Post NICU Discharge
Status: Enrolling,
Phase
Updated: 4/27/2018
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Frameless Fractionated Stereotactic Radiation in Treating Patients With Brain Metastases
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 6/13/2016
The Breast Program - Translational Cancer Resource
Status: Enrolling
Updated: 6/13/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Phase 1/2 Study of USL311 Alone and in Combination With Lomustine in Subjects With Advanced Solid Tumors and Relapsed/Recurrent Glioblastoma Multiforme (GBM)
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Liver Failure Clinical Trial
Updated: 12/31/1969
13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Liver Failure Clinical Trial
Updated: 12/31/1969
13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Liver Failure Clinical Trial
Updated: 12/31/1969
13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 6/16/2016
Pilot - Peri-operative Beta Blockade
Status: Enrolling,
Phase
IV
Updated: 6/16/2016
Click here to add this to my saved trials
Atherosclerotic Cardiovascular Disease Clinical Trial
Updated: 12/31/1969
Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Atherosclerotic Cardiovascular Disease Clinical Trial
Updated: 12/31/1969
Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Atherosclerotic Cardiovascular Disease Clinical Trial
Updated: 12/31/1969
Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Atherosclerotic Cardiovascular Disease Clinical Trial
Updated: 12/31/1969
Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Atherosclerotic Cardiovascular Disease Clinical Trial
Updated: 12/31/1969
Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Atherosclerotic Cardiovascular Disease Clinical Trial
Updated: 12/31/1969
Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Atherosclerotic Cardiovascular Disease Clinical Trial
Updated: 12/31/1969
Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Atherosclerotic Cardiovascular Disease Clinical Trial
Updated: 12/31/1969
Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Psychiatry / Psychology Clinical Trial
Updated: 6/20/2016
Blue Blockers and Insomnia
Status: Enrolling
Updated: 6/20/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab and BCG Solution in Treating Patients With Recurrent Non-Muscle-Invasive Bladder Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Ovarian Neoplasms Clinical Trial
Updated: 12/31/1969
Phase Ib Study of Anetumab Ravtansine in Combination With Pegylated Liposomal Doxorubicin in Patients With Recurrent Mesothelin-expressing Platinum-resistant Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Neoplasm Clinical Trial
Updated: 12/31/1969
18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Glaucoma Clinical Trial
Updated: 12/31/1969
The AGS Second Aqueous Shunt Implant vs. Transscleral Cyclophotocoagulation Treatment Study (ASSISTS)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Glaucoma Clinical Trial
Updated: 12/31/1969
The AGS Second Aqueous Shunt Implant vs. Transscleral Cyclophotocoagulation Treatment Study (ASSISTS)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Glaucoma Clinical Trial
Updated: 12/31/1969
The AGS Second Aqueous Shunt Implant vs. Transscleral Cyclophotocoagulation Treatment Study (ASSISTS)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Other Clinical Trial
Updated: 4/23/2018
Venous Leg Ulcer and Lymphedema Registry
Status: Enrolling,
Phase
Updated: 4/23/2018
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Glaucoma Clinical Trial
Updated: 12/31/1969
Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-1)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Glaucoma Clinical Trial
Updated: 12/31/1969
Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-1)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Glaucoma Clinical Trial
Updated: 12/31/1969
Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-3)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Glaucoma Clinical Trial
Updated: 12/31/1969
Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-3)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Glaucoma Clinical Trial
Updated: 12/31/1969
Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-3)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 5/8/2017
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 5/8/2017
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials